Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Single-cell gain-of-function mapping reveals latent regulatory programs governing CD8+ T cell fate.
Journal: Research square
Published: June 22, 2026
Latent Regulatory Programs Generate Synthetic T Cell States with Enhanced Therapeutic Potential.
Journal: bioRxiv : the preprint server for biology
Published: January 16, 2026
A patient-mediated implementation strategy to improve nutrition care delivery for esophageal and gastric cancer: a study protocol for a pilot randomized controlled trial.
Journal: Journal of health, population, and nutrition
Published: November 10, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer.
Journal: JCO precision oncology
Published: September 02, 2025
KRAS: the Achilles' heel of pancreas cancer biology.
Journal: The Journal of clinical investigation
Published: August 19, 2025
Phase II single-arm study of palbociclib and cetuximab in anti-EGFR naïve patients with KRAS/NRAS/BRAF wild-type, metastatic colorectal cancer.
Journal: The oncologist
Published: July 15, 2025
MET alterations are enriched in lung adenocarcinoma brain metastases, defining a distinct biologic subtype.
Journal: The Journal of clinical investigation
Published: May 09, 2025
Dysfunctional CD11c-CD21- extrafollicular memory B cells are enriched in the periphery and tumors of patients with cancer.
Journal: Science translational medicine
Published: February 19, 2025
Exploring the Role of Patient Preferences in Hepatocellular Carcinoma Treatment Decisions: A Qualitative Study.
Journal: MDM policy & practice
Published: December 04, 2024
Phase II study of avelumab and trastuzumab with FOLFOX chemotherapy in previously untreated HER2-amplified metastatic gastroesophageal adenocarcinoma.
Journal: The oncologist
Published: November 17, 2024
Feasibility trial of STRONG: A digital intervention to improve nutritional management for individuals with esophageal and gastroesophageal junction cancer.
Journal: Contemporary clinical trials communications
Published: October 18, 2024
Brief Report: Phase II Clinical Trial of Atezolizumab in Advanced Nonsmall Cell Lung Cancer Patients Previously Treated With PD-1-Directed Therapy.
Journal: Clinical lung cancer
Published: August 28, 2024
Last Updated: 09/26/2026